Medical Devices Africa

Africa Biological Age Testing Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

Africa Biological Age Testing Market Industry Trends and Forecast to 2034: Segmented by (Test, Channel, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Africa · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $14.8 Mn Placeholder estimate
Estimate 2025 $17.0 Mn 1.7% of the global market
Projected 2034 $56.0 Mn 230.4% Adds $39.1 Mn over 9 forecast years
CAGR 2025–2034 14.2% Faster than 83% of 173 Medical Devices markets here
Key players 5 Companies profiled
  • Africa is 1.66% of the global market.
  • Among regions, the largest is North America at $520.1 Mn.
  • Fastest growing: Latin America at 14.3% a year.
  • Africa ranks 6th of 6 by size among regions.

Market size projection

Africa

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$39.1 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Biological Age Testing Market market size by year, Africa
YearMarket sizeChange that yearSince 2025
2024 (estimate) $14.8 Mn — —
2025 (base) $17.0 Mn +$2.1 Mn —
2026 (forecast) $19.4 Mn +$2.4 Mn +14.2%
2027 (forecast) $22.1 Mn +$2.7 Mn +30.4%
2028 (forecast) $25.3 Mn +$3.1 Mn +48.9%
2029 (forecast) $28.8 Mn +$3.6 Mn +70.1%
2030 (forecast) $32.9 Mn +$4.1 Mn +94.2%
2031 (forecast) $37.6 Mn +$4.7 Mn +121.8%
2032 (forecast) $42.9 Mn +$5.3 Mn +153.3%
2033 (forecast) $49.0 Mn +$6.1 Mn +189.3%
2034 (forecast) $56.0 Mn +$7.0 Mn +230.4%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Africa Biological Age Testing Market Analysis at a glance
Market size, 2025$17.0 Mn placeholder estimate
Forecast, 2034$56.0 Mn placeholder estimate
Growth (CAGR), 2025–203414.2% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsTest, channel and end user (see all)
Key playersTruDiagnostic, Tally Health, InsideTracker, GlycanAge, Elysium Health (see all)
Regulator in AfricaAMASource: African Union, African Medicines Agency treaty. Checked 14 Nov 2026.
Active clinical trials1 in AfricaSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Africa. Retrieved 12 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Africa Biological Age Testing Market Analysis Executive Summary

Biological age tests estimate how fast a person is ageing using DNA methylation, blood markers or other data, rather than their age in years.

Key segments of the biological Age Testing market include test (Epigenetic Clocks, Blood Biomarker Panels and Telomere Tests) and channel (Direct-to-Consumer, Clinics and Research).

Bar chart: Africa Biological Age Testing market size, 2024–2034, placeholder estimates. $14.8 Mn in 2024, $17.0 Mn in 2025 and $56.0 Mn in 2034, 14.2% CAGR.
Africa Biological Age Testing market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Africa Biological Age Testing Market Dynamics

Market Growth Drivers

An ageing population, longer life expectancy, rising interest in healthy ageing and new science on how the body ages are driving the biological Age Testing market. Older adults and their families are spending more on staying active and independent.

Opportunity

Preventive care, personalised plans based on biomarkers and home-based services give the biological Age Testing market room to grow, especially in fast-ageing countries in Asia and Europe.

Market Restraints

Limited clinical proof for some longevity products, high out-of-pocket costs, regulation that does not treat ageing as a disease and uneven access hold back the biological Age Testing market.

Competitive Landscape for Biological Age Testing Market in Africa

The biological Age Testing market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Biological Age Testing Market in Africa

Biological Age Testing in Africa: rules, payment and research

The African Medicines Agency (AMA) treaty covers medical devices and diagnostics as well as medicines; national regulators still approve products.⁠[1] In some of the countries we cover here, medical devices are regulated by EDA (Egypt)⁠[2], PPB (Kenya)⁠[3] and SAHPRA (South Africa)⁠[4]. How care is paid for in some of these countries: universal health insurance (Egypt)⁠[5], the SHA (Kenya)⁠[6] and planned National Health Insurance (South Africa)⁠[7]. ClinicalTrials.gov lists 1 study on Biological Age Testing that is recruiting, active or about to start in Africa.⁠[8]

[1] African Union, African Medicines Agency treaty. Checked 14 Nov 2026.

[2] Egyptian Drug Authority. Checked 14 Nov 2026.

[3] Pharmacy and Poisons Board. Checked 14 Nov 2026.

[4] South African Health Products Regulatory Authority. Checked 14 Nov 2026.

[5] Universal Health Insurance Authority. Checked 14 Nov 2026.

[6] Social Health Authority. Checked 14 Nov 2026.

[7] National Department of Health. Checked 14 Nov 2026.

[8] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Africa. Retrieved 12 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how biological Age Testing products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Africa.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Biological Age Testing right now, from free public sources.

Clinical trials

1 active trial in Egypt, South Africa, Kenya, Nigeria, Ethiopia, DR Congo, Uganda, Tanzania, Niger, Mozambique, Sudan, Malawi, Zambia, Mali, Burkina Faso, Ghana and Morocco

Recruiting, about to start, or running now. Counted across the 17 countries we report on in Africa.

Top trial sponsors (worldwide)

  1. Longevity Metrics, Inc. 3 active trials on ClinicalTrials.gov (opens in a new tab)
  2. Nutraland USA, Inc. 2 active trials on ClinicalTrials.gov (opens in a new tab)
  3. Elysium Health 2 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

See every trial on ClinicalTrials.gov (opens in a new tab)

Patients

People aged 65 and over, % of people (World Bank)
CountryValueYear
Burkina Faso2.72025
DR Congo3.12025
Egypt5.32025
Ethiopia3.32025
Ghana3.82025
Kenya3.02025
Malawi2.62025
Mali2.42025
Morocco8.52025
Mozambique2.72025
Niger2.62025
Nigeria3.12025
South Africa6.92025
Sudan3.42025
Tanzania3.02025
Uganda2.22025
Zambia2.02025
Compare every country on the Public Health Dashboard

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 16 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Biological Age Testing in context

Free data on this topic

Quick answers

Frequently asked questions

How big is the Biological Age Testing market in Africa?
Placeholder estimate: about $17.0 Mn in 2025, rising to about $56.0 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Biological Age Testing market in Africa growing?
Placeholder estimate: about 14.2% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Biological Age Testing market report cover?
The report splits the market by test (Epigenetic Clocks, Blood Biomarker Panels, Telomere Tests, Multi-Omic Tests), channel (Direct-to-Consumer, Clinics, Research) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Biological Age Testing market?
Key players include TruDiagnostic, Tally Health, InsideTracker, GlycanAge and Elysium Health.
What is driving the Biological Age Testing market?
An ageing population, longer life expectancy, rising interest in healthy ageing and new science on how the body ages are driving the biological Age Testing market. Older adults and their families are spending more on staying active and independent.
Who regulates Biological Age Testing in Africa?
The African Medicines Agency (AMA) treaty covers medical devices and diagnostics as well as medicines; national regulators still approve products. Source: African Union, African Medicines Agency treaty. Checked 14 Nov 2026.
How many clinical trials on Biological Age Testing are running in Africa?
1 study is recruiting, active or about to start in Africa, counted across the 17 countries we report on there, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Africa. Retrieved 12 Nov 2026.
How much research is published on Biological Age Testing?
PubMed lists 803 papers on Biological Age Testing added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Medical Devices reports in Africa

See all

Related on geriatric and genomics

See the topic